Compounds, compositions and methods
AA Estrada, JA Feng, B Fox, CP Leslie… - US Patent …, 2017 - Google Patents
2017-08-08 Assigned to DENALI THERAPEUTICS INC. reassignment DENALI
THERAPEUTICS INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
THERAPEUTICS INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
RIP1 inhibitory compounds and methods for making and using the same
E Masuda, S Shaw, V Taylor, S Bhamidipati - US Patent 10,815,206, 2020 - Google Patents
Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1
(RIP1) kinase inhibitor com pounds, as well as pharmaceutical compositions and com …
(RIP1) kinase inhibitor com pounds, as well as pharmaceutical compositions and com …
RIP1 inhibitory compounds and methods for making and using the same
V Taylor, J Yu, E Masuda, I Darwish… - US Patent 10,975,064, 2021 - Google Patents
Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1
(RIP1) kinase inhibitor com pounds, as well as pharmaceutical compositions and com …
(RIP1) kinase inhibitor com pounds, as well as pharmaceutical compositions and com …
Compounds, compositions and methods
AA Estrada, JA Feng, B Fox, ZK Sweeney - US Patent 9,896,458, 2018 - Google Patents
2018-02-13 Assigned to DENALI THERAPEUTICS INC. reassignment DENALI
THERAPEUTICS INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
THERAPEUTICS INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
Compounds, compositions and methods
AA Estrada, JA Feng, B Fox, CP Leslie… - US Patent …, 2018 - Google Patents
2018-05-02 Assigned to DENALI THERAPEUTICS INC. reassignment DENALI
THERAPEUTICS INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
THERAPEUTICS INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
Heterocyclic RIP1 kinase inhibitors
S Shaw, S Bhamidipati, V Taylor - US Patent 11,479,543, 2022 - Google Patents
Related US Application Data (60) Provisional application No. 62/897,223, filed on Sep. 6,
2019, provisional application No. 62/932,404, filed on Nov. 7, 2019, provisional application …
2019, provisional application No. 62/932,404, filed on Nov. 7, 2019, provisional application …
RIP1 inhibitory compounds and methods for making and using the same
Y Chen, J Yu, S Shaw, I Darwish, V Taylor… - US Patent …, 2022 - Google Patents
2021-03-23 Assigned to RIGEL PHARMACEUTICALS, INC. reassignment RIGEL
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Heterocyclic amides as kinase inhibitors
2018-08-10 Assigned to GLAXOSMITHKLINE INTELLECTUAL PROPERTY
DEVELOPMENT LIMITED reassignment GLAXOSMITHKLINE INTELLECTUAL PROPERTY …
DEVELOPMENT LIMITED reassignment GLAXOSMITHKLINE INTELLECTUAL PROPERTY …
RIP1 inhibitory compounds and methods for making and using the same
J Yu, I Darwish, V Taylor, R Kolluri, Y Chen… - US Patent …, 2023 - Google Patents
Provisional application No. 63/004319, filed on Apr. 2, 2020, provisional application No.
63/004,290, filed on Apr. 2, 2020, provisional application No. 63/001,016, filed on Mar. 27 …
63/004,290, filed on Apr. 2, 2020, provisional application No. 63/001,016, filed on Mar. 27 …
RIP1 inhibitory compounds and methods for making and using the same
E Masuda, S Shaw, V Taylor, S Bhamidipati - US Patent 11,377,428, 2022 - Google Patents
Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1
(RIP1) kinase inhibitor com pounds, as well as pharmaceutical compositions and com …
(RIP1) kinase inhibitor com pounds, as well as pharmaceutical compositions and com …